 Enlivex Therapeutics Ltd. ENLV, a clinical-stage immunotherapy company, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 8:00 AM ET. Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines Cytokine Release Syndrome and for which there are no approved treatments unmet medical needs, as well as solid tumors immune-checkpoint rebalancing. 